Gynecologic Care of Transgender Men Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Gynecologic Care of Transgender Men. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Gynecologic Care of Transgender Men Indian Medical PG Question 1: Which of the following screening methods is NOT effective for early detection of cancer in asymptomatic women?
- A. USG in endometrial cancer
- B. CA-125 for ovarian cancer (Correct Answer)
- C. Pap smear for cervical cancer
- D. Mammography for breast cancer
Gynecologic Care of Transgender Men Explanation: ***CA-125 for ovarian cancer***
- **CA-125 lacks sufficient sensitivity and specificity** for screening asymptomatic women, leading to high rates of **false positives** and **false negatives**.
- Major randomized trials (**UKCTOCS, PLCO**) demonstrated **no mortality benefit** from CA-125 screening and increased unnecessary invasive procedures.
*USG in endometrial cancer*
- **Transvaginal ultrasonography** effectively measures **endometrial thickness** and aids in risk stratification for symptomatic women.
- While not used for population screening, it serves as a valuable **diagnostic adjunct** in evaluating postmenopausal bleeding and guiding biopsy decisions.
*Pap smear for cervical cancer*
- The **Pap smear** is the **gold standard** screening method that has dramatically reduced cervical cancer incidence and mortality.
- It effectively detects **precancerous lesions** (CIN) and early cervical cancers, allowing for timely intervention and treatment.
*Mammography for breast cancer*
- **Mammography screening** is proven effective in reducing **breast cancer mortality** by 20-40% in women aged 50-69 years.
- It can detect **early-stage breast cancers** and **microcalcifications** before they become palpable, enabling early treatment.
Gynecologic Care of Transgender Men Indian Medical PG Question 2: Which of the following hormones will be affected most after the change in sex hormone binding globulin?
- A. Testosterone (Correct Answer)
- B. Progesterone
- C. DHEA
- D. Estrogen
Gynecologic Care of Transgender Men Explanation: ***Testosterone***
- **Sex hormone-binding globulin (SHBG)** binds primarily to **testosterone** (and dihydrotestosterone) with **high affinity**.
- SHBG has approximately **5 times greater affinity** for testosterone compared to estradiol.
- A change in SHBG levels will significantly impact the proportion of **free (biologically active) testosterone** available in the circulation, thus affecting its overall function and measurement.
- This makes testosterone the hormone **most affected** by changes in SHBG levels.
*Progesterone*
- **Progesterone** is primarily bound to **albumin** and **corticosteroid-binding globulin (CBG)**, not SHBG.
- Therefore, changes in SHBG would have minimal direct impact on progesterone levels or its bioavailability.
*DHEA*
- **Dehydroepiandrosterone (DHEA)** is mostly bound to **albumin** in the blood.
- Its binding to SHBG is negligible, making changes in SHBG irrelevant to its overall circulating levels or activity.
*Estrogen*
- **Estrogen (estradiol)** also binds to SHBG, but with **significantly lower affinity** than testosterone (approximately 5-fold less).
- While affected by SHBG changes, the impact is less pronounced than on testosterone due to the lower binding affinity and its additional binding to albumin.
Gynecologic Care of Transgender Men Indian Medical PG Question 3: Continuous GnRH therapy is used in All EXCEPT.
- A. Precocious puberty
- B. Prostate cancer
- C. Male infertility (Correct Answer)
- D. Endometriosis
Gynecologic Care of Transgender Men Explanation: ***Male infertility***
- **Pulsatile GnRH therapy** is used to stimulate gonadotropin secretion and subsequent testosterone production in hypogonadotropic hypogonadism, which can cause male infertility.
- **Continuous GnRH therapy** causes downregulation of GnRH receptors leading to suppression of gonadotropin release, which would worsen male infertility.
*Precocious puberty*
- Continuous GnRH therapy (GnRH agonists) is used to suppress the **pituitary-gonadal axis**, effectively stopping the progression of precocious puberty.
- By continuously stimulating GnRH receptors, it leads to their **desensitization and downregulation**, preventing the pulsatile release of LH and FSH.
*Prostate cancer*
- Continuous GnRH therapy (GnRH agonists) is used for **androgen deprivation therapy**, suppressing testosterone production, which fuels prostate cancer growth.
- This effectively creates a chemical castration effect by **downregulating GnRH receptors** on pituitary gonadotrophs.
*Endometriosis*
- Continuous GnRH therapy (GnRH agonists) is used to induce a **hypoestrogenic state**, which helps shrink endometrial implants.
- By continuously stimulating GnRH receptors, it leads to their **desensitization and downregulation**, reducing estrogen production from the ovaries.
Gynecologic Care of Transgender Men Indian Medical PG Question 4: What is the recommended treatment for children with mild to moderate symptoms of COVID-19?
- A. Antiviral therapy
- B. Supportive care (Correct Answer)
- C. Corticosteroids
- D. Antibiotics
Gynecologic Care of Transgender Men Explanation: ***Supportive care***
- For children with **mild to moderate COVID-19 symptoms**, **supportive care** is the cornerstone of treatment, focusing on symptom relief.
- This includes **rest**, **hydration**, and **fever-reducing medications** (e.g., acetaminophen or ibuprofen) as needed.
*Antiviral therapy*
- **Antiviral medications** like Paxlovid are generally reserved for older children and adolescents with **severe COVID-19** or those at **high risk for progression to severe disease**.
- They are not typically recommended for mild to moderate cases in children due to potential side effects and the usually self-limiting nature of the illness.
*Corticosteroids*
- **Corticosteroids** (e.g., dexamethasone) are primarily used in children with **severe COVID-19** who require **oxygen support** or have significant inflammation.
- They are not indicated for mild to moderate cases, as their benefits are outweighed by potential adverse effects in this population.
*Antibiotics*
- **Antibiotics** are effective against **bacterial infections** and have no role in treating **viral illnesses** like COVID-19.
- They should only be used if a **secondary bacterial infection** is suspected or confirmed.
Gynecologic Care of Transgender Men Indian Medical PG Question 5: A 4-year-old girl weighing 12 kg, with diarrhea, skin pinch that goes back very slowly, and who is unable to drink, is most likely to:
- A. Start IV fluids per Plan C (Correct Answer)
- B. Discharge home with oral fluids
- C. Monitor for worsening dehydration
- D. Attempt oral rehydration with ORS
Gynecologic Care of Transgender Men Explanation: ***Start IV fluids per Plan C***
- The child presents with **severe dehydration** based on WHO criteria: **skin pinch goes back very slowly** (>2 seconds) and **unable to drink**.
- These two signs mandate immediate **Plan C management** which involves rapid IV fluid resuscitation using **Ringer's Lactate or Normal Saline**.
- WHO Plan C protocol: Give **100 ml/kg** IV fluids divided as 30 ml/kg in first hour (if <12 months) or first 30 minutes (if ≥12 months), then 70 ml/kg over next 2.5-5 hours.
- Plan C is specifically designed for **severe dehydration** requiring immediate intravenous rehydration, not Plan B which is for moderate dehydration with oral rehydration.
*Discharge home with oral fluids*
- Discharging a child with **severe dehydration** is inappropriate and potentially life-threatening.
- The child **cannot drink** effectively, making home management with oral fluids impossible and dangerous.
- This would lead to worsening dehydration, shock, and potentially fatal complications.
*Monitor for worsening dehydration*
- While monitoring is important, this child requires **immediate active intervention**, not observation alone.
- Delaying IV rehydration in a child with **severe dehydration** (unable to drink, very slow skin pinch) could lead to hypovolemic shock, acute kidney injury, and death.
*Attempt oral rehydration with ORS*
- This child is **unable to drink**, making ORS ineffective and contraindicated.
- Oral rehydration (Plan B) is appropriate only for **moderate dehydration** in children who are conscious, alert, and able to drink.
- Attempting ORS in a child unable to drink delays appropriate IV therapy and worsens outcomes.
Gynecologic Care of Transgender Men Indian Medical PG Question 6: A woman with postmenopausal bleeding has thickened endometrium. Which approach is most suitable for evaluating malignancy risk?
- A. Endometrial biopsy (Correct Answer)
- B. Transvaginal ultrasound
- C. Pap smear
- D. Hysteroscopy
Gynecologic Care of Transgender Men Explanation: ***Endometrial biopsy***
- An **endometrial biopsy** directly obtains tissue samples from the endometrial lining, allowing for histological examination to definitively diagnose or rule out **endometrial hyperplasia** or **carcinoma**.
- This is the **most suitable first-line approach** when postmenopausal bleeding is coupled with a thickened endometrium, as it directly assesses for **malignancy at a cellular level**.
- It is **cost-effective, minimally invasive, and can be performed in an office setting** without anesthesia.
*Transvaginal ultrasound*
- While a **transvaginal ultrasound** can measure endometrial thickness and identify structural abnormalities, it cannot definitively differentiate between benign and malignant changes.
- It serves as an initial screening tool but requires further investigation like a **biopsy** for definitive diagnosis in cases of thickened endometrium and postmenopausal bleeding.
- An endometrial thickness >4-5 mm in postmenopausal women warrants tissue diagnosis.
*Pap smear*
- A **Pap smear** (Papanicolaou test) is used to screen for **cervical cancer** by collecting cells from the cervix.
- It is not effective for detecting **endometrial pathologies** or cancer of the uterine lining.
*Hysteroscopy*
- **Hysteroscopy** allows for direct visualization of the uterine cavity and directed biopsies under direct vision, which is highly accurate for identifying focal lesions such as polyps or fibroids.
- While it provides excellent diagnostic accuracy, it is **more invasive, expensive, and typically requires anesthesia**.
- For initial evaluation of postmenopausal bleeding with diffuse endometrial thickening, **endometrial biopsy is preferred** as the first-line approach due to its accessibility, lower cost, and adequate sensitivity (>90% for detecting endometrial cancer).
Gynecologic Care of Transgender Men Indian Medical PG Question 7: A Post-Menopausal woman complains of spotting per vaginum after 5 years of menopause. USG reveals endometrial thickness of 7 mm and an intramural fibroid of size 3cm. Next step in management is?
- A. CA 125 levels
- B. Paps smear and follow up
- C. Myomectomy
- D. Endometrial biopsy (Correct Answer)
Gynecologic Care of Transgender Men Explanation: ***Endometrial biopsy***
- Post-menopausal **vaginal bleeding** or spotting, especially with an **endometrial thickness of ≥ 4-5 mm** on ultrasound, is highly suspicious for endometrial hyperplasia or carcinoma and warrants an endometrial biopsy for definitive diagnosis.
- An endometrial biopsy is crucial to rule out endometrial malignancy, as this is the primary concern in such presentations.
*CA 125 levels*
- **CA 125** is primarily used as a tumor marker for **ovarian cancer** surveillance and response to treatment, not for initial diagnosis of post-menopausal bleeding or endometrial pathology.
- Elevated CA 125 can be found in various benign conditions as well and is not specific enough to guide the initial management of post-menopausal bleeding without tissue sampling.
*Paps smear and follow up*
- A **Pap smear** screens for **cervical abnormalities** and **cervical cancer**, not endometrial pathology.
- While it's part of routine gynecological care, it will not address the investigation of post-menopausal bleeding originating from the uterus.
*Myomectomy*
- **Myomectomy** is a surgical procedure to remove **uterine fibroids**, typically when they are causing symptoms like heavy menstrual bleeding or pressure.
- In a post-menopausal woman with spotting, the intramural fibroid may or may not be directly responsible, and the priority is to exclude **endometrial cancer** before considering fibroid-specific interventions.
Gynecologic Care of Transgender Men Indian Medical PG Question 8: Treatment of endometrial hyperplasia with atypia in a 45-year-old female:
- A. Progestin
- B. Mirena
- C. Hysterectomy (Correct Answer)
- D. Endometrial ablation
Gynecologic Care of Transgender Men Explanation: ***Hysterectomy***
- **Endometrial hyperplasia with atypia** carries a significant risk of progression to **endometrial cancer**, ranging from 20% to 50% over several years, making hysterectomy a definitive treatment option.
- For a 45-year-old female, especially if she has completed childbearing or is nearing menopause, a **hysterectomy** eliminates the uterine pathology and prevents future recurrence or malignant transformation.
*Progestin*
- While progestin therapy can be used for endometrial hyperplasia without atypia or for atypical hyperplasia in women who desire to preserve fertility, its effectiveness for **simple atypical hyperplasia** is 70-80%.
- The risk of residual or coexisting carcinoma, and the potential for recurrence if fertility is not a concern, makes progestin a less definitive treatment than hysterectomy in this age group.
*Mirena*
- The **Mirena IUD** (levonorgestrel-releasing intrauterine system) delivers local progestin, which is effective for **endometrial hyperplasia without atypia** and is sometimes used for atypical hyperplasia when fertility preservation is desired.
- However, for **atypical hyperplasia**, which has a notable risk of malignancy, a more definitive treatment like hysterectomy is generally preferred, especially as Mirena's systemic effects are limited and regular follow-up biopsies are needed.
*Endometrial ablation*
- **Endometrial ablation** destroys the endometrial lining and is typically used for managing **heavy menstrual bleeding (menorrhagia)** when fertility is not desired.
- It is **contraindicated in cases of endometrial hyperplasia with atypia** due to the risk of obscuring underlying or developing malignancy and making future surveillance difficult.
Gynecologic Care of Transgender Men Indian Medical PG Question 9: The most appropriate management of a 32 weeks pregnant lady with carcinoma cervix stage IIb is.
- A. Observation and follow-up
- B. Chemo-radiation followed by labour induction and vaginal delivery
- C. Labour induction, vaginal delivery followed by radio-therapy
- D. Cesarean delivery followed by chemoradiation (Correct Answer)
Gynecologic Care of Transgender Men Explanation: ***Cesarean delivery followed by chemoradiation***
- For **stage IIb carcinoma cervix** at 32 weeks gestation, **cesarean delivery** is the safest option to deliver the baby while avoiding trauma to the tumor and potential dissemination.
- Subsequently, **chemoradiation** is the standard treatment for stage IIb cervical cancer, ensuring optimal maternal oncologic outcome.
*Observation and follow-up*
- This approach is **inappropriate** for stage IIb cervical cancer in pregnancy, as it delays definitive treatment and allows for disease progression.
- Such an aggressive cancer requires **prompt intervention** for the best maternal prognosis.
*Chemo-radiation followed by labour induction and vaginal delivery*
- **Chemoradiation during pregnancy** is harmful to the fetus, especially beyond the first trimester.
- A **vaginal delivery** in the presence of cervical cancer carries a high risk of hemorrhage and tumor dissemination, making it contraindicated.
*Labour induction, vaginal delivery followed by radio-therapy*
- **Labour induction and vaginal delivery** are contraindicated due to risks of hemorrhage, tumor spread, and potential obstruction from the tumor.
- While radiotherapy would follow, the mode of delivery poses significant risks to the mother.
Gynecologic Care of Transgender Men Indian Medical PG Question 10: A multidisciplinary team is developing protocols for adolescent gender-affirming care. When evaluating the appropriateness of GnRH analog therapy versus immediate cross-sex hormones in a 16-year-old with persistent gender dysphoria (Tanner stage 5), which factor most strongly supports proceeding directly to cross-sex hormones?
- A. Parental consent is available
- B. Mental health evaluation shows no contraindications
- C. Completion of pubertal development makes GnRH analogs ineffective (Correct Answer)
- D. Patient expresses strong desire for rapid physical changes
Gynecologic Care of Transgender Men Explanation: ***Completion of pubertal development makes GnRH analogs ineffective***
- **GnRH analogs** are primarily used to suppress the progression of endogenous puberty; once a patient has reached **Tanner stage 5**, biological puberty is complete, rendering suppression redundant.
- At this physiological stage, initiating **cross-sex hormones** (gender-affirming hormone therapy) is the appropriate clinical step to align physical characteristics with gender identity.
*Parental consent is available*
- While **parental consent** is a legal and ethical requirement for treating minors, it does not dictate the physiological choice between suppression and hormone therapy.
- Consent is necessary for either **GnRH analogs** or **cross-sex hormones**, but the patient's **Tanner stage** is the medical deciding factor here.
*Mental health evaluation shows no contraindications*
- A thorough **mental health evaluation** is a prerequisite for all gender-affirming medical interventions to ensure the diagnosis of **gender dysphoria**.
- While it confirms readiness for treatment, it does not differentiate which specific endocrine intervention is biologically appropriate for a **Tanner 5** adolescent.
*Patient expresses strong desire for rapid physical changes*
- **Patient autonomy** and goals are vital, but clinical protocols prioritize developmental staging over the desired speed of changes to ensure safety.
- Although **cross-sex hormones** do produce rapid changes compared to analogs, the medical rationale for skipping analogs is the **completion of puberty**, not patient preference.
More Gynecologic Care of Transgender Men Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
